AML-VAC-XS15-01: protocol of a first-in-human clinical trial to evaluate the safety, tolerability and preliminary efficacy of a multi-peptide vaccine based on leukemia stem cell antigens in acute myeloid leukemia patients

DSpace Repository

AML-VAC-XS15-01: protocol of a first-in-human clinical trial to evaluate the safety, tolerability and preliminary efficacy of a multi-peptide vaccine based on leukemia stem cell antigens in acute myeloid leukemia patients

Author: Jung, Susanne; Nelde, Annika; Maringer, Yacine; Denk, Monika; Zieschang, Lisa; Kammer, Christine; Oezbek, Melek; Martus, Peter; Hackenbruch, Christopher; Englisch, Alexander; Heitmann, Jonas S.; Salih, Helmut R.; Walz, Juliane S.
Tübinger Autor(en):
Jung, Susanne
Nelde, Annika
Maringer, Yacine
Denk, Monika
Zieschang, Lisa
Kammer, Christine
Martus, Peter
Hackenbruch, Christopher
Englisch, Alexander
Heitmann, Jonas S.
Salih, Helmut R.
Walz, Juliane S.
Oezbek, Melek T.
Published in: Frontiers in Oncology (2024), Bd. 14, Article 1458449
Verlagsangabe: Lausanne : Frontiers Media Sa
Language: English
Full text: http://dx.doi.org/10.3389/fonc.2024.1458449
ISSN: 2234-943X
DDC Classifikation: 610 - Medicine and health
Dokumentart: Article
Show full item record

This item appears in the following Collection(s)